Literature DB >> 6893680

Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252.

A S Sun, A I Cederbaum.   

Abstract

Experiments were carried out to determine if the difference in rates of cell proliferation between normal and neoplastic cells may be related to altered levels of oxidative enzymes. Assays were performed using homogenates from hepatocellular carcinoma HC-252, a rapidly growing and moderately well-differentiated tumor; from normal liver; and from the liver of the tumor-bearing ACI rat. Results of the mitochondrial enzymes indicated that the activities of cytochrome oxidase and succinate dehydrogenase were 3-fold lower in tumor homogenates than in liver homogenates. Monoamine oxidase activity could not be detected in HC-252; mixing experiments indicated no inhibitor was present in HC-252. Activities of th peroxisomal enzymes, urate oxidase, D-amino acid oxidase, and L-alpha-hydroxy acid oxidase were either undetected in the tumor or were 12-fold lower than in liver homogenates. The activity of xanthine oxidase, a cytoplasmic enzyme, was 5- to 6-fold lower in the tumor. Catalase activity in the tumor was also lower than in liver; this may be indicative of a lower oxidative environment at the cellular level. These enzyme activities of the liver of tumor-bearing rats were in the same range as those of normal rat liver, except that D-amino acid oxidase activity was slightly lower, and catalase activity was markedly lower and varied in a wide range. These results show an inverse correlation between the activities of oxygen-utilizing enzymes and rates of proliferation of one tumor line and its control. The possible implications of these results in neoplasia, cell proliferation, and cellular aging are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893680

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Did pangolins spread the China coronavirus to people?

Authors:  David Cyranoski
Journal:  Nature       Date:  2020-02-07       Impact factor: 49.962

Review 2.  Mitochondrial subversion in cancer.

Authors:  Aditi Chatterjee; Santanu Dasgupta; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

3.  Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells.

Authors:  Claudia R Oliva; Tahireh Markert; Larry J Ross; E Lucile White; Lynn Rasmussen; Wei Zhang; Maaike Everts; Douglas R Moellering; Shannon M Bailey; Mark J Suto; Corinne E Griguer
Journal:  J Biol Chem       Date:  2016-09-27       Impact factor: 5.157

4.  Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group.

Authors:  Ozgur Tanriverdi; Suna Cokmert; Esin Oktay; Kezban Nur Pilanci; Serkan Menekse; Muharrem Kocar; Cenk Ahmet Sen; Nilufer Avci; Tulay Akman; Cetin Ordu; Gamze Goksel; Nezih Meydan
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

5.  Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps.

Authors:  LaShanale Wallace; Sharifeh Mehrabi; Methode Bacanamwo; Xuebiao Yao; Felix O Aikhionbare
Journal:  Tumour Biol       Date:  2016-06-22

Review 6.  The proliferating cell hypothesis: a metabolic framework for Plasmodium growth and development.

Authors:  J Enrique Salcedo-Sora; Eva Caamano-Gutierrez; Stephen A Ward; Giancarlo A Biagini
Journal:  Trends Parasitol       Date:  2014-03-11

Review 7.  Xanthine oxidoreductase in cancer: more than a differentiation marker.

Authors:  Maria Giulia Battelli; Letizia Polito; Massimo Bortolotti; Andrea Bolognesi
Journal:  Cancer Med       Date:  2015-12-21       Impact factor: 4.452

8.  Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology.

Authors:  Lambert C M Ngoka
Journal:  Proteome Sci       Date:  2008-10-24       Impact factor: 2.480

9.  Contribution of uric acid to cancer risk, recurrence, and mortality.

Authors:  Mehdi A Fini; Anthony Elias; Richard J Johnson; Richard M Wright
Journal:  Clin Transl Med       Date:  2012-08-15

Review 10.  Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects.

Authors:  Maria Giulia Battelli; Letizia Polito; Massimo Bortolotti; Andrea Bolognesi
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.